{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T06:05:32Z","timestamp":1788156332177,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"DOI":"10.1038\/s41389-026-00621-5","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:04:33Z","timestamp":1778205873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ubiquitin-specific protease 11 suppresses cuproptosis in colorectal cancer by regulating the ubiquitination and stability of ISCU"],"prefix":"10.1038","volume":"15","author":[{"given":"Hailin","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuecui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8210-2579","authenticated-orcid":false,"given":"Songling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"621_CR1","first-page":"198","volume":"21","author":"JC Fabregas","year":"2022","unstructured":"Fabregas JC, Ramnaraign B, George TJ. Clinical updates for colon cancer care in 2022. Clin Colorectal Cancer. 2022;21:198\u2013203.","journal-title":"Clin Colorectal Cancer"},{"key":"621_CR2","first-page":"89","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14:89\u2013103.","journal-title":"Prz Gastroenterol"},{"key":"621_CR3","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354.","journal-title":"CA Cancer J Clin"},{"key":"621_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"Y-H Xie","year":"2020","unstructured":"Xie Y-H, Chen Y-X, Fang J-Y. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5:22.","journal-title":"Signal Transduct Target Ther"},{"key":"621_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.dld.2023.11.041","volume":"56","author":"V Balboa-Barreiro","year":"2024","unstructured":"Balboa-Barreiro V, P\u00e9rtega-D\u00edaz S, Garc\u00eda-Rodr\u00edguez T, Gonz\u00e1lez-Mart\u00edn C, Pardeiro-P\u00e9rtega R, Y\u00e1\u00f1ez-Gonz\u00e1lez-Dopeso L, et al. Colorectal cancer recurrence and its impact on survival after curative surgery: an analysis based on multistate models. Dig Liver Dis. 2024;56:1229\u201336.","journal-title":"Dig Liver Dis"},{"key":"621_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.6004\/jnccn.2018.0021","volume":"16","author":"AB Benson","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen Y-J, Ciombor KK, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018;16:359\u201369.","journal-title":"J Natl Compr Canc Netw"},{"key":"621_CR7","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/cancers13092025","volume":"13","author":"T Sawicki","year":"2021","unstructured":"Sawicki T, Ruszkowska M, Danielewicz A, Nied\u017awiedzka E, Ar\u0142ukowicz T, Przyby\u0142owicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 2021;13:2025.","journal-title":"Cancers"},{"key":"621_CR8","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.molcel.2022.05.001","volume":"82","author":"PA Cobine","year":"2022","unstructured":"Cobine PA, Brady DC. Cuproptosis: cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell. 2022;82:1786\u20137.","journal-title":"Mol Cell"},{"key":"621_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"621_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y, et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updates. 2024;72:101018.","journal-title":"Drug Resist Updates"},{"key":"621_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378.","journal-title":"Signal Transduct Target Ther"},{"key":"621_CR12","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3390\/cancers15082286","volume":"15","author":"Z Wu","year":"2023","unstructured":"Wu Z, Lin C, Zhang F, Lu Z, Wang Y, Liu Y, et al. TIGD1 function as a potential cuproptosis regulator following a novel cuproptosis-related gene risk signature in colorectal cancer. Cancers. 2023;15:2286.","journal-title":"Cancers"},{"key":"621_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1566986","volume":"15","author":"C Jiang","year":"2025","unstructured":"Jiang C, Xin H, Liu Y, Han Y. Cuproptosis as a therapeutic target in cancer: a systematic review and bibliometric analysis of the research landscape. Front Oncol. 2025;15:1566986.","journal-title":"Front Oncol"},{"key":"621_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander D, Rape M. The ubiquitin code. Annu Rev Biochem. 2012;81:203\u201329.","journal-title":"Annu Rev Biochem"},{"key":"621_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrm3099","volume":"12","author":"C Grabbe","year":"2011","unstructured":"Grabbe C, Husnjak K, Dikic I. The spatial and temporal organization of ubiquitin networks. Nat Rev Mol cell Biol. 2011;12:295\u2013307.","journal-title":"Nat Rev Mol cell Biol"},{"key":"621_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3389\/fonc.2019.01406","volume":"9","author":"X Xu","year":"2019","unstructured":"Xu X, Li S, Cui X, Han K, Wang J, Hou X, et al. Inhibition of ubiquitin specific protease 1 sensitizes colorectal cancer cells to DNA-damaging chemotherapeutics. Front Oncol. 2019;9:1406.","journal-title":"Front Oncol"},{"key":"621_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/0008-5472.CAN-14-3595","volume":"76","author":"C Xing","year":"2016","unstructured":"Xing C, Lu X-X, Guo P-D, Shen T, Zhang S, He X-S, et al. Ubiquitin-specific protease 4-mediated deubiquitination and stabilization of PRL-3 is required for potentiating colorectal oncogenesis. Cancer Res. 2016;76:83\u201395.","journal-title":"Cancer Res"},{"key":"621_CR18","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/cbin.11358","volume":"44","author":"T Huang","year":"2020","unstructured":"Huang T, Zhang Q, Ren W, Yan B, Yi L, Tang T, et al. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt\/\u03b2-catenin pathway via Axin1 deubiquitination. Cell Biol Int. 2020;44:1651\u20139.","journal-title":"Cell Biol Int"},{"key":"621_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2025.05.429","volume":"237","author":"L Yao","year":"2025","unstructured":"Yao L, Ye S, Xu D. UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma. Free Radic Biol Med. 2025;237:65\u201375.","journal-title":"Free Radic Biol Med"},{"key":"621_CR20","doi-asserted-by":"publisher","first-page":"e02501","DOI":"10.1002\/advs.202502501","volume":"12","author":"L Li","year":"2025","unstructured":"Li L, Wang Y, Tian R, Yang T, Liu Y, Shan B, et al. TRIM21-mediated K11-linked ubiquitination of ID1 suppresses tumorigenesis and promotes cuproptosis in esophageal squamous cell carcinoma. Adv Sci. 2025;12:e02501.","journal-title":"Adv Sci"},{"key":"621_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04533-5","volume":"21","author":"M Tarin","year":"2023","unstructured":"Tarin M, Babaie M, Eshghi H, Matin MM, Saljooghi AS. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications. J Transl Med. 2023;21:745.","journal-title":"J Transl Med"},{"key":"621_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70245-5","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Qiu S, Shao S, Cao Y, Hong Y, Xu X, et al. NMN partially rescues cuproptosis by upregulating sirt2 to increase intracellular NADPH. Sci Rep. 2024;14:19392.","journal-title":"Sci Rep"},{"key":"621_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.freeradbiomed.2023.05.017","volume":"204","author":"J Du","year":"2023","unstructured":"Du J, Huang Z, Li Y, Ren X, Zhou C, Liu R, et al. Copper exerts cytotoxicity through inhibition of iron-sulfur cluster biogenesis on ISCA1\/ISCA2\/ISCU assembly proteins. Free Radic Biol Med. 2023;204:359\u201373.","journal-title":"Free Radic Biol Med"},{"key":"621_CR24","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.scib.2025.05.019","volume":"70","author":"L Chen","year":"2025","unstructured":"Chen L, Wu Q, Lin C, Song Z, Su Y, Ge C, et al. Integrative analysis of copper dysregulation and cuproptosis in postnatal hematopoiesis. Sci Bull. 2025;70:2658\u201375.","journal-title":"Sci Bull"},{"key":"621_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129979","volume":"1865","author":"B Blades","year":"2021","unstructured":"Blades B, Ayton S, Hung YH, Bush AI, La Fontaine S. Copper and lipid metabolism: a reciprocal relationship. Biochim Biophys Acta Gen Subj. 2021;1865:129979.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"621_CR26","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/01.pas.0000126757.58474.12","volume":"28","author":"DK McGregor","year":"2004","unstructured":"McGregor DK, Wu TT, Rashid A, Luthra R, Hamilton SR. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol. 2004;28:712\u20138.","journal-title":"Am J Surg Pathol"},{"key":"621_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/CMAR.S411168","volume":"15","author":"K He","year":"2023","unstructured":"He K, Gan WJ. Wnt\/\u03b2-catenin signaling pathway in the development and progression of colorectal cancer. Cancer Manag Res. 2023;15:435\u201348.","journal-title":"Cancer Manag Res"},{"key":"621_CR28","first-page":"480","volume":"13","author":"YY Huang","year":"2021","unstructured":"Huang YY, Zhang CM, Dai YB, Lin JG, Lin N, Huang ZX, et al. USP11 facilitates colorectal cancer proliferation and metastasis by regulating IGF2BP3 stability. Am J Transl Res. 2021;13:480\u201396.","journal-title":"Am J Transl Res"},{"key":"621_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41419-024-07188-2","volume":"15","author":"Y Lu","year":"2024","unstructured":"Lu Y, wei W, Li M, Chen D, Li W, Hu Q, et al. The USP11\/Nrf2 positive feedback loop promotes colorectal cancer progression by inhibiting mitochondrial apoptosis. Cell Death Dis. 2024;15:873.","journal-title":"Cell Death Dis"},{"key":"621_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ebiom.2019.09.022","volume":"48","author":"U Malapelle","year":"2019","unstructured":"Malapelle U. USP11 role in colorectal cancer growing and metastatisation. EBioMedicine. 2019;48:5\u20136.","journal-title":"EBioMedicine"},{"key":"621_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9963905","volume":"2022","author":"T Guo","year":"2022","unstructured":"Guo T, Tang H, Yuan Z, Zhang E, Wang X. The dual role of USP11 in cancer. J Oncol. 2022;2022:9963905.","journal-title":"J Oncol"},{"key":"621_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12957-021-02173-x","volume":"19","author":"W Zhang","year":"2021","unstructured":"Zhang W, Wang Z, Cai G, Huang P. Circ_DOCK1 regulates USP11 through miR-132-3p to control colorectal cancer progression. World J Surg Oncol. 2021;19:67.","journal-title":"World J Surg Oncol"},{"key":"621_CR33","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1021\/bi9002277","volume":"48","author":"JH Kim","year":"2009","unstructured":"Kim JH, F\u00fcz\u00e9ry AK, Tonelli M, Ta DT, Westler WM, Vickery LE, et al. Structure and dynamics of the iron\u2212sulfur cluster assembly scaffold protein IscU and its interaction with the cochaperone HscB. Biochemistry. 2009;48:6062\u201371.","journal-title":"Biochemistry"},{"key":"621_CR34","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1093\/emboj\/19.21.5692","volume":"19","author":"WH Tong","year":"2000","unstructured":"Tong WH, Rouault T. Distinct iron\u2013sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells. EMBO J. 2000;19:5692\u2013700.","journal-title":"EMBO J"},{"key":"621_CR35","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajhg.2007.12.012","volume":"82","author":"F Mochel","year":"2008","unstructured":"Mochel F, Knight MA, Tong W-H, Hernandez D, Ayyad K, Taivassalo T, et al. Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance. Am J Hum Genet. 2008;82:652\u201360.","journal-title":"Am J Hum Genet"},{"key":"621_CR36","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fgene.2025.1605440","volume":"16","author":"JM Rusecka","year":"2025","unstructured":"Rusecka JM, Ceccatelli Berti C, Szcz\u0119\u015bniak D, Bednarska-Makaruk M, Mroczek M, Kacprzak MM, et al. Autosomal dominant myopathy caused by a novel ISCU variant. Front Genet. 2025;16:2025.","journal-title":"Front Genet"},{"key":"621_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep16497","volume":"5","author":"Y Funauchi","year":"2015","unstructured":"Funauchi Y, Tanikawa C, Yi Lo PH, Mori J, Daigo Y, Takano A, et al. Regulation of iron homeostasis by the p53-ISCU pathway. Sci Rep. 2015;5:16497.","journal-title":"Sci Rep"},{"key":"621_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41421-023-00558-8","volume":"9","author":"X Ren","year":"2023","unstructured":"Ren X, Yan J, Zhao Q, Bao X, Han X, Zheng C, et al. The Fe-S cluster assembly protein IscU2 increases \u03b1-ketoglutarate catabolism and DNA 5mC to promote tumor growth. Cell Discov. 2023;9:76.","journal-title":"Cell Discov"},{"key":"621_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2009.08.015","volume":"10","author":"SY Chan","year":"2009","unstructured":"Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1\/2. Cell Metab. 2009;10:273\u201384.","journal-title":"Cell Metab"},{"key":"621_CR40","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1074\/jbc.M112.424499","volume":"288","author":"P La","year":"2013","unstructured":"La P, Yang G, Dennery PA. Mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation stabilizes ISCU protein: implications for iron metabolism. J Biol Chem. 2013;288:12901\u20139.","journal-title":"J Biol Chem"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00621-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00621-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00621-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:13:58Z","timestamp":1782915238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00621-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1038\/s41389-026-00621-5","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human colon cancer tissues collected from the Second Affiliated Hospital of Xiamen Medical College under approvement from the Ethics Committee of Second Affiliated Hospital of Xiamen Medical College (approved No.2022043). All procedures were performed in accordance with the ethical standards of responsible committee on human experimentation (institutional and national), and with Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"34"}}